If the risk of mass delistings is as real as some claim, with the obvious implications for patients, then surely it needs to be part of any forum hosted by or even involving the industry? …
Surely the best 'patient view' is one that is fully informed?
September 2, 2022 Latest NewsBioPharmaComment
Latest Video
New Stories
-
The 'Dispatched' Week in Review Podcast - 25 September
September 25, 2026 - - Podcast -
Pharmac opens patient recruitment to new advisory committee
September 25, 2026 - - Latest News -
Boehringer Ingelheim stays in Macquarie Park with new ANZ headquarters
September 25, 2026 - - Latest News -
If AI causes a breach of confidentiality protections, who is to blame?
September 25, 2026 - - Latest News -
AI and the fine print of the government's 'Health Products Portal'
September 25, 2026 - - Latest News -
Canberra is outraged that AI accessed data without asking - others know the feeling
September 24, 2026 - - Latest News -
AI is already in the decision-making process, but where is the conversation about its use?
September 24, 2026 - - Latest News